RECITALS:License and Technology Transfer Agreement • February 20th, 2003 • Haemacure Corp • Surgical & medical instruments & apparatus
EX-10.20 9 dex1020.htm LICENSE AND TECHNOLOGY TRANSFER AGREEMENT CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF...License and Technology Transfer Agreement • May 5th, 2020 • California
This License and Technology Transfer Agreement (the “Agreement”) effective this 21st day of December, 2007 (the “Effective Date”) by and between Ariane Controls inc., (“Ariane”) and Enphase Energy Inc., (“Enphase”). (Ariane and Enphase may be referred to individually as a “Party” and collectively as the “Parties”).
RECEPTOS CONFIDENTIAL LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • April 16th, 2013 • Receptos, Inc. • Pharmaceutical preparations • New York
This License and Technology Transfer Agreement (the “Agreement”) is made as of December 28, 2010 (the “Effective Date”) by and between Receptos, Inc., a Delaware corporation (“Receptos”) located at 10835 Road to the Cure, Suite #205, San Diego, California 92121 and Ortho-McNeil-Janssen Pharmaceuticals, Inc., a Pennsylvania corporation (“Company”) having an address at 1125 Trenton-Harbour Road, Titusville, New Jersey 08650.
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • August 26th, 2015 • England
This License And Technology Transfer Agreement is made and entered into on this 20th day of November, 2015 (Effective Date) by and between:
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • July 1st, 2004 • Netlogic Microsystems Inc • Semiconductors & related devices • New York
This LICENSE AND TECHNOLOGY TRANSFER AGREEMENT (this “Agreement”), dated as of December 12, 2002 (the “Effective Date”) and amended as of May 7, 2003, is made by and between Micron Technology, Inc., a Delaware corporation (“MTI”) and NetLogic Microsystems, Inc., a Delaware corporation (“NetLogic”), (each of NetLogic and MTI, a “Party”; together the “Parties”).
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • June 14th, 2022 • New York
This License and Technology Transfer Agreement is made and entered into as of the 15th day of June, 2022 (Effective Date) by and between:
MANUFACTURING LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • November 13th, 2006 • Accuray Inc
This Manufacturing License and Technology Transfer Agreement ("Agreement") is made and entered into this 28th day of January, 1991, by and between Schonberg Radiation Corporation, a California corporation having its principal place of business in Santa Clara, California ("Company"), and Accuray Associates, a California limited partnership having its principal place of business in Santa Clara, California ("Licensee").
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • November 12th, 2010 • Sunpower Corp • Semiconductors & related devices • California
This LICENSE AND TECHNOLOGY TRANSFER AGREEMENT (“Agreement”) is made and entered into as of July 5, 2010, by and among (i) SunPower Technology, Ltd., a company organized under the laws of the Cayman Islands (“SPTL”); (ii) AU Optronics Singapore Pte. Ltd., a company organized under the laws of Singapore (“AUO”); and (iii) SunPower Malaysia Manufacturing SDN.BHD., a company organized under the laws of Malaysia (the “JVC”). Each of SPTL, AUO and the JVC may be referred to herein as a “Party” and together as the “Parties.”
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • June 15th, 2011 • Enphase Energy, Inc. • California
This License and Technology Transfer Agreement (the “Agreement”) effective this 21st day of December, 2007 (the “Effective Date”) by and between Ariane Controls inc., (“Ariane”) and Enphase Energy Inc., (“Enphase”). (Ariane and Enphase may be referred to individually as a “Party” and collectively as the “Parties”).
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • September 5th, 2024 • England
This License And Technology Transfer Agreement is made and entered into on this 20th day of November, 2015 (Effective Date) by and between:
LICENSE AND TECHNOLOGY TRANSFER AGREEMENT between CIDARA THERAPEUTICS, INC. and JANSSEN PHARMACEUTICALS, INC. April 23, 2024License and Technology Transfer Agreement • August 13th, 2024 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This License and Technology Transfer Agreement (this “Agreement”), dated as of April 23, 2024 (the “Execution Date”), is entered into by and between Cidara Therapeutics, Inc., a Delaware corporation, having an address of 6310 Nancy Ridge Drive, Suite 101, San Diego, CA 92121 (“Cidara”), and Janssen Pharmaceuticals, Inc., a corporation organized and existing under the laws of Pennsylvania, with its principal business office located at 1125 Trenton-Harbourton Road, Titusville, NJ 08560 (“Janssen”). Cidara and Janssen are each sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AND TECHNOLOGY TRANSFER AGREEMENTLicense and Technology Transfer Agreement • December 12th, 2013 • England
Each of BMS and MPP is referred to in this Agreement as a Party. BMS and MPP are collectively referred to in this Agreement as the Parties.
